To explore whether the link between serum complement C3 levels and NAFLD is independent of obesity and metabolic syndrome, we excluded 2383 participants who were obese (BMI ≥ 25 kg/m2) and/or had metabolic syndrome for subgroup analysis. The gene discussed is C3; the disease is metabolic dysfunction-associated steatotic liver disease.